On Feb. 7, 2024, Jedd Fisch stated his goal was to sign the best recruiting class in Washington’s history during the 2025 recruiting cycle. At the time, Fisch’s proclamation seemed like a stretch.

Drew Swanson is a Features Article Editor from the Pacific Northwest of the United States. He is a lifelong gamer with a passion for a variety of genres. A connoisseur of everything from JRPGs and ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Derin Yilmaz began her editorial work as a culture and entertainment writer, reviewing films, music, and TV. Her passion for food media ignited when she contributed to Sweet July, a lifestyle brand ...

The Air Force is yanking most of its biggest programs out from its existing program-management structure and putting them under a new four-star who reports to the deputy defense secretary. On Tuesday, ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

The U.S. government shutdown deal includes hundreds of millions of dollars for construction projects needed to base the B-21 Raider stealth bomber at several Air Force bases. (Kyle Brasier/Air Force) ...

HOUSTON – House-hunting shouldn’t feel impossible. But for Martin Campusano and millions of prospective buyers across Texas, the biggest obstacle isn’t interest rates or search fatigue — it’s the down ...

The professor will no longer be able to teach a class on diversity after she showed students a diagram that included the “Make America Great Again” slogan as an example of white supremacy. By ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a ...